Latest News

Scott+Scott Attorneys at Law LLP Reminds Investors of Securities Class Action Against Sibanye Gold Limited (SBGL) and August 27 Lead Plaintiff Deadline

Tuesday August 14 th 2018

NEW YORK, Aug. 14, 2018 /PRNewswire/ – Scott+Scott Attorneys at Law LLP (“Scott+Scott”), a national securities and consumer rights litigation firm, reminds investors that a class action lawsuit has been filed against Sibanye Gold Limited (NYSE: SBGL) (“Sibanye” or the “Company”) and other defendants, related to alleged violations of federal securities laws.  If you purchased Sibanyestock or securities between April 7, 2017 and June 26, 2018, you are encouraged to contact a Scott+Scott attorney at (844) 818-6982 for additional information.  The deadline to more for lead plaintiff isAugust 27, 2018.

The lawsuit alleges that defendants made false and/or misleading statements and/or failed to disclose that:  (i) Sibanye’s safety protocols were inadequate to prevent a high rate of worker death; (ii) Sibanye’s mining supervisors routinely forced Company employees to work in unsafe and unlawful conditions; (iii) the foregoing issues would foreseeably subject Sibanye to heightened regulatory oversight; and (iv) as a result, Sibanye’s public statements were materially false and misleading at all relevant times.  When the truth was revealed, investors suffered damages.  Additional information is available here:

What You Can Do

If you purchased Sibanye shares or securities between April 7, 2017 and June 26, 2018, inclusive, or if you have questions about this notice or your legal rights, please contact attorney Joe Pettigrew at (844) 818-6982, or at 

About Scott+Scott Attorneys at Law LLP

Scott+Scott has significant experience in prosecuting major securities, antitrust, and employee retirement plan actions throughout the United States.  The firm represents pension funds, foundations, individuals, and other entities worldwide with offices in New York, London, Connecticut, California, and Ohio.

Attorney Advertising

Joe Pettigrew
Scott+Scott Attorneys at Law LLP 
230 Park Ave, 17 Fl, NY, NY 10169-1820 
(844) 818-6982 


Cision View original content:

SOURCE Scott+Scott Attorneys at Law LLP

Freedonia Analyst Weighs in on Brink’s Acquisition of Dunbar Armored, a Move That Combines the Second and Fourth Largest Cash-in-Transit Firms

CLEVELAND, Aug. 14, 2018 /PRNewswire/ – On August 13, the Brink’s Company completed its acquisition of Dunbar Armored Incorporated (Hunt Valley, MD) for $520 million. This deal combines the second and fourth largest cash-in-transit firms.

Freedonia Group logo (PRNewsFoto/The Freedonia Group)

According to Brink’s, “The acquisition will expand and differentiate Brink’s customer base with Dunbar’s complementary focus on small-to-medium sized retailers and financial institutions.”

According to Freedonia Group analyst Jennifer Mapes-Christ, “The US market for cash-in-transit and related services is highly concentrated, with the top four service providers accounting for nearly three-quarters of all revenue. This purchase will propel Brink’s to the leading position in the US market.”

Furthermore, she notes, “Barriers to entry are higher in this segment than in other types of security services. These include the technology costs associated with the armored transport vehicles, communications systems, tracking devices, and advanced safes; high insurance premiums; and the need for armed guards that are not only more difficult to hire than unarmed guards, but more expensive to train and retain.”

Mapes-Christ adds, “Additionally, the well-established brands of the market leaders help; with the liability risks surrounding security mishaps, most business, government, and institutional clients are extremely sensitive to vendor reputations. Brink’s and Dunbar are among those well-known brands.”

She continues, “However, the need for companies to be flexible is increasing. In response to changes in traditional cash handling resulting from rising e-commerce and cashless transactions, service providers have invested in areas such as secured logistics as well as value-added cash management and ATM services.”

Additional analysis of the private security industry can be found in the following Freedonia reports: Global Security Services Market and Private Security Services in the US. For more information on these and other security industry studies, please see Freedonia’s Security segment.

About The Freedonia Group – The Freedonia Group, a division of, is a leading international industrial research company publishing more than 100 studies annually. Since 1985 we have provided research to customers ranging in size from global conglomerates to one-person consulting firms. More than 90% of the industrial companies in the Fortune 500 use Freedonia Group research to help with their strategic planning. Each study includes product and market analyses and forecasts, in-depth discussions of important industry trends, and market share information. Studies can be purchased at and are also available on and

Press Contact:
Corinne Gangloff
+1 440.684.9600


Cision View original content with multimedia:

SOURCE The Freedonia Group

Tri City Dental Care Founder, Dr. Antonio Lopez-Ibarra, understands care and compassion first hand

KENNEWICK, Wash., Aug. 14, 2018 /PRNewswire/ – A desire to help people with compassion and caring about their health is not exclusive to any culture, language, or heritage.  It begins with a deep-rooted desire to help patients and then having the drive and determination to be the best while not forgetting everyone is a person. This philosophy was instilled in Dr. Antonio López-Ibarra, Founder of Tri City Dental Care, at an early age by his parents.

“All of us can relate to fear and discomfort of the unknown.  I saw the struggles my family experienced growing up.  It takes faith, an outstanding family, determination, and desire to make everyone feel safe,” says the 33-year old father of three. “We look beyond stereotypes of language, culture, and heritage. Our practice is solely designed to treat our patients like family so they relax and feel safe.”

The understanding and caring staff are bi-lingual and can speak and understand dental issues in Spanish and English. Feeling understood and being at ease is critical in fixing dental problems and improving oral health.

Education is a key to success. Dr. López-Ibarra received his dental degree at the University of Washington. He comes from a rich tradition of serving people through dentistry and sciences as 5 other family members practice medicine. His passion for dentistry comes from his extensive experience in family dentistry. He routinely studies the latest techniques serves the dental needs of families and people of all ages. The payoff is what his actual patients say.

Whether a long-time patient at Tri City Dental or it’s a first visit, the relaxing atmosphere and friendly smiles instantly make even the most skittish patient instantly relax.  Unique services are available such as customized massage chairs, aromatherapy, and even a paraffin hand treatment. 

Tri City Dental Care offers cleanings, crowns and fillings; they specialize in preventive care. The practice offers dental implants, Invisalign, and reconstructive surgery.  Dr. López-Ibarra understands true vision is being able to look farther than he can see.  When he sees patients, he doesn’t see a person’s heritage, upbringing, or language.  He sees another man, woman, or child that needs compassion free from pain and discomfort. To learn more about all the Tri City Dental Care Services, click here. or call (509) 579-0759.  Relief for any dental problem and peace of mind is a phone call away.


Tri City Dental Care Logo

Cision View original content with multimedia:

SOURCE Tri City Dental Care

Global Genitourinary Partnering 2012-2018: Deal trends, players and financials

LONDON, August 14, 2018 /PRNewswire/ — Global Genitourinary Partnering 2012 to 2018 provides the full collection of Genitourinary disease deals signed between the world’s pharmaceutical and biotechnology companies since 2012.

Download the full report:

Trends in Genitourinary partnering deals
Financial deal terms for headline, upfront and royalty by stage of development
Genitourinary partnering agreement structure
Genitourinary partnering contract documents
Top Genitourinary deals by value
Most active Genitourinary dealmakers

Most of the deals included within the report occur when a licensee obtains a right or an option right to license a licensor’s product or technology. More often these days these deals tend to be multi-component including both a collaborative RD and a commercialization of outcomes element.

The report takes readers through the comprehensive Genitourinary disease deal trends, key players and top deal values allowing the understanding of how, why and under what terms companies are currently entering Genitourinary deals.

The report presents financial deal terms values for Genitourinary deals, where available listing by overall headline values, upfront payments, milestones and royalties enabling readers to analyse and benchmark the value of current deals.

The initial chapters of this report provide an orientation of Genitourinary dealmaking trends.

Chapter 1 provides an introduction to the report.

Chapter 2 provides an overview of the trends in Genitourinary dealmaking since 2012 covering trends by year, deal type, stage of development, technology type and therapeutic indication.

Chapter 3 includes an analysis of financial deal terms covering headline value, upfront payment, milestone payments and royalty rates.

Chapter 4 provides a review of the leading Genitourinary deals since 2012. Deals are listed by headline value. The chapter includes the top 25 most active Genitourinary dealmakers, together with a full listing of deals to which they are a party. Where the deal has an agreement contract published at the SEC a link provides online access to the contract.

Chapter 5 provides comprehensive access to Genitourinary deals since 2012 where a deal contract is available, providing the user with direct access to contracts as filed with the SEC regulatory authorities. Each deal title links via Weblink to an online version of the deal record contract document, providing easy access to each contract document on demand.

Chapter 6 provides a comprehensive directory of all Genitourinary partnering deals by specific Genitourinary target announced since 2012. The chapter is organized by specific Genitourinary therapeutic target. Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.

In addition, a comprehensive appendix is provided with each report of all Genitourinary partnering deals signed and announced since 2012. The appendices are organized by company A-Z, stage of development at signing, deal type (collaborative RD, co-promotion, licensing etc) and technology type. Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.

The report also includes numerous tables and figures that illustrate the trends and activities in Genitourinary partnering and dealmaking since 2012.

In conclusion, this report provides everything a prospective dealmaker needs to know about partnering in the research, development and commercialization of Genitourinary technologies and products.

Report scope
Global Genitourinary Partnering 2012 to 2018 is intended to provide the reader with an in-depth understanding and access to Genitourinary trends and structure of deals entered into by leading companies worldwide.

Global Genitourinary Partnering 2012 to 2018 includes:
Trends in Genitourinary dealmaking in the biopharma industry since 2012
Analysis of Genitourinary deal structure
Access to headline, upfront, milestone and royalty data
Access to hundreds of Genitourinary deal contract documents
Comprehensive access to over 3500 Genitourinary deal records
The leading Genitourinary deals by value since 2012
Most active Genitourinary dealmakers since 2012

The report includes deals for the following indications: Discharge, Frequency, Incontinence, Itching, Nocturia, Urgency, Acute kidney injury, Amyloidosis, Chronic kidney disease (CKD), Cystitis, Diabetic nephropathy, Dialysis, Hemolytic-uremic syndrome (HUS), Kidney stones, Nephrotic syndrom, Overactive bladder, Peyronie’s disease, Polycystic kidney disease, Prostate diseases, Prostatitis, Prostate enlargement, Renal failure, Renal infections, Nephritis, Glomerulonephritis, Pyelonephritis, Vesicoureteral reflux, Urinary tract infection (UTI), plus other genitourinary indications.

In Global Genitourinary Partnering 2012 to 2018, available deals and contracts are listed by:
Headline value
Upfront payment value
Royalty rate value
Stage of development at signing
Deal component type
Technology type
Specific therapy indication

Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.

The Global Genitourinary Partnering 2012 to 2018 report provides comprehensive access to available deals and contract documents for over 3500 Genitourinary deals. Analyzing actual contract agreements allows assessment of the following:
• What are the precise Genitourinary rights granted or optioned?
• What is actually granted by the agreement to the partner company?
• What exclusivity is granted?
• What is the payment structure for the deal?
• How aresalesand payments audited?
• What is the deal term?
• How are the key terms of the agreement defined?
• How are IPRs handled and owned?
• Who is responsible for commercialization?
• Who is responsible for development, supply, and manufacture?
• How is confidentiality and publication managed?
• How are disputes to be resolved?
• Under what conditions can the deal be terminated?
• What happens when there is a change of ownership?
• What sublicensing and subcontracting provisions have been agreed?
• Which boilerplate clauses does the company insist upon?
• Which boilerplate clauses appear to differ from partner to partner or deal type to deal type?
• Which jurisdiction does the company insist upon for agreement law?

Download the full report:

About Reportbuyer
Reportbuyer is a leading industry intelligence solution that provides all market research reports from top publishers

For more information:
Sarah Smith
Research Advisor at
Tel: +1 (718) 213 4904

Cision View original content:

SOURCE ReportBuyer

DATUM and Zaloni partner to provide customers Data Value from Big Data to Big Enterprise

ANNAPOLIS, Md., Aug. 14, 2018 /PRNewswire/ – DATUM, a leader in data governance, stewardship and metadata management software, today announced a partnership with Zaloni, whose self-service data platform, ZDP, provides industry- leading data lake management and governance capabilities. with the leading solution provider of Data Lakes, Zaloni.  Driven by the vision of creating a metadata catalog that serves both the business users who wants to be able to determine what data they have and where to locate it, and the technical data provider who wants to be able to add new data sets and sources – altogether allowing for an automated way of linking data assets to business definitions and governance rules critical to an enterprise data ecosystem.

DATUM provides data governance and stewardship technology that helps large enterprises chart and navigate their best course to digital leadership.

DATUM provides an Information Governance framework that helps organizations manage enterprise data governance policies. It is purpose-built to discover, understand, connect and measure data value throughout an organization.  Zaloni provides an operational framework for implementing these policies as part of a modern data platform. Together DATUM and Zaloni provide enterprise level data governance from big data to big enterprise and deliver the full Information Value lifecycle for an organization. 

“Our partnership with Zaloni allows us to unify the conversation and reference model between the business subject matter expert, data engineers, and the data science function to achieve meaningful, measurable return from data assets” said Will Crump, DATUM President CEO.

By combining a business-focused metadata management platform with deep functionality in data preparation, the joint offering balances out the full picture of an organization’s need to visualize the connection between business goals and objectives through to the enforcement level of policies, standards and rules. An end-to-end lineage can be traced from the business lineage in data as well as the technical lineage in how data moves through the ecosystem.

“The Zaloni-DATUM partnership was born out of hearing from customers and partners who wanted to be able to better leverage all the hard work that they put into defining their processes, standards, rules, dictionaries and glossaries. Combining DATUM’s Information Value Management platform with the Zaloni Data Platform (ZDP) allows us to deliver the definition around policies that in turn are operationalized in the Zaloni Data Platform,” said Ben Sharma, Zaloni’s CEO.

“I believe the heritage of both our organizations and our practical experiences standing shoulder-to-shoulder with our customers when delivering large enterprise data strategies and Big Data solutions have taught us to listen to the customers and to anticipate their future needs in operating their business,” said DATUM President CEO, Will Crump. “The Zaloni partnership is a natural extension for focus on delivering Data Value for our customers”.

About Zaloni
Zaloni simplifies data management for transformative business insights. We work with pioneering enterprises to modernize their data architecture and operationalize their data lakes to incorporate data into everyday business practices. The Zaloni Data Platform (ZDP) provides total control throughout the data pipeline from ingestion to analytics, with comprehensive data management, governance and self-service data preparation capabilities for IT and business users. A leader in big data for more than a decade, Zaloni’s expertise is deep, spans multiple industries, and has proven invaluable to customers at many of the world’s top companies. We are proud to be recognized by CRN’s 2018 Big Data 100 list, Forbes top 20 big data companies to work for, and Red Herring’s Top 100 North America Award. To learn more, visit

Recognized as a Leader in The Forrester Waveâ„¢: Data Governance, Stewardship and Discovery Providers, and as a Leader in the Gartner Magic Quadrant for Metadata Management Solutions, DATUM drives decision integrity, empowering organizations to discover the right data and make the right decisions faster. By focusing on what data matters and why, DATUM’s proven data governance and stewardship platform, Information Value Management®, delivers business value insights. Today, Fortune 500′s trust DATUM as the data governance system of record to improve operational efficiency, deliver greater analytical insights and simplify compliance and regulatory reporting. To learn more, visit

Media Contacts:
Marie Crump, DATUM LLC

Annie Bishop, Zaloni

Cision View original content with multimedia: